
Loading, please wait...

Loading, please wait...

Propofol is the most widely used intravenous anesthetic agent in modern clinical practice. However, doctors often face challenges due to the significant interindividual variability in how patients respond to the drug. To address these variations, researchers have developed a high-throughput method for plasma propofol quantification. This advancement is essential because current population-based dosing algorithms often fail to provide the precision required for every surgical patient.
Specifically, the study details a new liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay. This method utilizes protein precipitation to achieve a rapid total run-time of only 5.5 minutes. Furthermore, the assay demonstrates remarkable accuracy and stability across a broad quantification range of 25 to 5000 ng/mL. Consequently, this reliable tool allows for the efficient processing of large-scale samples in clinical pharmacokinetic studies. Additionally, the method remains robust even under various storage and handling conditions, ensuring data integrity.
The primary utility of this bioanalytical method lies in its ability to inform pharmacokinetic-pharmacodynamic modeling. By providing accurate plasma propofol quantification data, the assay helps refine Target-Controlled Infusion (TCI) algorithms. As a result, anesthesiologists can develop more individualized dosing strategies for patients undergoing major noncardiac surgery. In conclusion, this fit-for-purpose method significantly supports the transition toward more personalized and safer anesthetic management.
It allows researchers to precisely measure drug concentrations, which is vital for creating accurate dosing models that account for individual patient differences.
The assay is highly efficient with a 5.5-minute run-time and offers high extraction recovery. It also remains stable under various conditions like freeze-thaw cycles and long-term storage.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed a robust LC-MS/MS assay for plasma propofol quantification to improve target-controlled infusion algorithms and individualized dosing....
4 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today